The International Diabetes Federation suggested that pro-inflammatory states including rises in levels of high-sensitivity CRP and cytokines, as well as a decrease in plasma adiponectin levels, needed to be added to clinical metabolic parameters of MetS [57]. The gene discussed is CRP; the disease is diabetes mellitus.